Inhibitory effect of gamma interferon on BK virus gene expression and replication

Journal of Virology

Volumn 81, Issue 1, 2007, Pages 272-279

  Abend, Johanna R ^a   Low, Jonathan A ^a,b   Imperiale, Michael J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY PROTEIN LARGE TUMOR ANTIGEN; GAMMA INTERFERON; PROTEIN VP1; TUMOR ANTIGEN;

ARTICLE; BK VIRUS; CONTROLLED STUDY; GENE EXPRESSION; GENE REPLICATION; GRAFT RECIPIENT; HUMAN; HUMAN CELL; INFECTION CONTROL; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BK VIRUS; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTERFERON TYPE II; KINETICS; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

BK POLYOMAVIRUS; POLYOMAVIRUS;

EID: 33845750574     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01571-06     Document Type: Article

References (42)

1. Bohl, D. L., G. A. Storch, C. Ryschkewitsch, M. Gaudreault-Keener, M. A. Schnitzler, E. O. Major, and D. C. Brennan. 2005. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am. J. Transplant. 5:2213-2221.
2. Briggs, J. P., W. Kriz, and J. B. Schnermann. 2001. Overview of renal function structure, p. 3-19. In A. Greenberg et al. (ed.), Primer on kidney diseases, 3rd ed. Academic Press, New York, NY.
3. Chen, Y., J. Trofe, J. Gordon, R. A. Du Pasquier, P. Roy-Chaudhury, M. J. Kuroda, E. S. Woodle, K. Khalili, and I. J. Koralnik. 2006. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J. Virol. 80:3495-3505.
4. Chesters, P. M., J. Heritage, and D. J. McCance. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147:676-684.
5. Comoli, P., A. Azzi, R. Maccario, S. Basso, G. Botti, G. Basile, I. Fontana, M. Labirio, A. Cometa, F. Poli, F. Perfumo, F. Locatelli, and F. Ginevri. 2004. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78:1229-1232.
6. Daha, M. R., and C. van Kooten. 2000. Is the proximal tubular cell a proinflammatory cell? Nephrol. Dial. Transplant. 15(Suppl. 6):41-43.
7. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.
8. de Veer, M. J., M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, R. H. Silverman, and B. R. Williams. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
9. Dörries, K., E. Vogel, S. Gunther, and S. Czub. 1994. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:59-70.
10. Drachenberg, C. B., H. H. Hirsch, E. Ramos, and J. C. Papadimitriou. 2005. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum. Pathol. 36:1245-1255.
11. Gardner, S. D., A. M. Field, D. V. Coleman, and B. Humle. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet i:1253-1257.
12. Hariharan, S., E. P. Cohen, B. Vasudev, R. Orentas, R. P. Viscidi, J. Kakela, and B. DuChateau. 2005. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am. J. Transplant. 5:2719-2724.
13. Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861-869.
14. Harlow, E., P. Whyte, B. R. Franza, Jr., and C. Schley. 1986. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol. Cell. Biol. 6:1579-1589.
15. Harms, J. S., and G. A. Splitter. 1995. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6:1291-1297.
16. Heritage, J., P. M. Chesters, and D. J. McCance. 1981. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J. Med. Virol. 8:143-150.
17. Hirsch, H. H. 2005. BK virus: opportunity makes a pathogen. Clin. Infect. Dis. 41:354-360.
18. Hirsch, H. H., D. C. Brennan, C. B. Drachenberg, F. Ginevri, J. Gordon, A. P. Limaye, M. J. Mihatsch, V. Nickeleit, E. Ramos, P. Randhawa, R. Shapiro, J. Steiger, M. Suthanthiran, and J. Trofe. 2005. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277-1286.
19. Hirsch, H. H., W. Knowles, M. Dickenmann, J. Passweg, T. Klimkait, M. J. Mihatsch, and J. Steiger. 2002. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 347:488-496.
20. Hirsch, H. H., and J. Steiger. 2003. Polyomavirus BK. Lancet Infect. Dis. 3:611-623.
21. Humes, H. D., W. H. Fissell, W. F. Weitzel, D. A. Buffington, A. J. Westover, S. M. MacKay, and J. M. Gutierrez. 2002. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am. J. Kidney Dis. 39:1078-1087.
22. Kerr, J. R., M. McCoy, B. Burke, D. L. Mattey, V. Pravica, and I. V. Hutchinson. 2003. Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection. J. Clin. Pathol. 56:725-727.
23. Knowles, W. A. 2001. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes, p. 527-559. In K. Khalili and G. L. Stoner (ed.), Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss Inc., New York, NY.
24. Lai, H. C., C. C. Chang, Y. W. Lin, S. F. Chen, M. H. Yu, S. Nieh, T. W. Chu, and T. Y. Chu. 2005. Genetic polymorphisms of the interferon-gamma gene in cervical carcinogenesis. Int. J. Cancer 113:712-718.
25. -ΔΔCT method. Methods 25:402-408.
26. López-Maderuelo, D., F. Arnalich, R. Serantes, A. Gonzalez, R. Codoceo, R. Madero, J. J. Vazquez, and C. Montiel. 2003. Interferon-gamma and interleukin-10 polymorphisms in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 167:970-975.
27. Low, J., H. D. Humes, M. Szczypka, and M. Imperiale. 2004. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 323:182-188.
28. Meneguzzi, G., P. F. Pignatti, G. Barbanti-Brodano, and G. Milanesi. 1978. Minichromosome from BK virus as a template for transcription in vitro. Proc. Natl. Acad. Sci. USA 75:1126-1130.
29. Moens, U., and O. P. Rekvig. 2001. Molecular biology of BK virus and clinical and basic aspects of BK virus renal infection, p. 359-408. In K. Khalili and G. L. Stoner (ed.), Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss Inc., New York, NY.
30. Nickeleit, V., H. K. Singh, and M. J. Mihatsch. 2003. Polyomavirus nephropathy: morphology, pathophysiology, and clinical management. Curr. Opin. Nephrol. Hypertens. 12:599-605.
31. Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202:8-32.
32. Pravica, V., A. Asderakis, C. Perrey, A. Hajeer, P. J. Sinnott, and I. V. Hutchinson. 1999. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur. J. Immunogenet. 26:1-3.
33. Pravica, V., C. Perrey, A. Stevens, J. H. Lee, and I. V. Hutchinson. 2000. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol. 61:863-866.
34. Qin, L., Y. Ding, D. R. Pahud, E. Chang, M. J. Imperiale, and J. S. Bromberg. 1997. Promoter attenuation in gene therapy, interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum. Gene Ther. 8:2019-2029.
35. Ritter, T., C. Brandt, S. Prosch, A. Vergopoulos, K. Vogt, J. Kolls, and H. D. Volk. 2000. Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells. Cytokine 12:1163-1170.
36. Rozen, S., and H. J. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers, p. 365-386. In S. Krawetz and S. Misener (ed.), Bioinformatics methods and protocols: methods in molecular biology. Humana Press, Totowa, NJ.
37. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
38. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
39. Shinohara, T., M. Matsuda, S. H. Cheng, J. Marshall, M. Fujita, and K. Nagashima. 1993. BK virus infection of the human urinary tract. J. Med. Virol. 41:301-305.
40. Sundsfjord, A., T. Flaegstad, R. Flo, A. R. Spein, M. Pedersen, H. Permin, J. Julsrud, and T. Traavik. 1994. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J. Infect. Dis. 169:485-490.
41. Sundsfjord, A., T. Johansen, T. Flaegstad, U. Moens, P. Villand, S. Subramani, and T. Traavik. 1990. At least two types of control regions can be found among naturally occurring BK virus strains. J. Virol. 64:3864-3871.
42. Wheelock, E. F. 1965. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149:310-311.